Related references
Note: Only part of the references are listed.Genetic variations in angiogenesis pathway genes associated with clinical outcome in localized gastric adenocarcinoma
G. Lurje et al.
ANNALS OF ONCOLOGY (2010)
Genetic Variations in Angiogenesis Pathway Genes Predict Tumor Recurrence in Localized Adenocarcinoma of the Esophagus
Georg Lurje et al.
ANNALS OF SURGERY (2010)
Epidemiology and pathophysiology of cancer-associated thrombosis
S. Noble et al.
BRITISH JOURNAL OF CANCER (2010)
Dihydrofolate reductase (DHRF) 19-bp intron-1 deletion and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms in breast cancer
Ragip Cam et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Factor V Leiden and prothrombin G20210A polymorphisms are not associated with disease-free survival in breast cancer
Aydan Eroglu et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
The Risk of Cancer Progression in Women With Gynecological Malignancies and Thrombophilic Polymorphisms: A Pilot Case-Control Study
Daniela Tormene et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2009)
Proteinase-activated receptor-1 - Triggered activation of tumor progression locus-2 promotes actin cytoskeleton reorganization and cell migration
Maria Hatziapostolou et al.
CANCER RESEARCH (2008)
Association study of protease activated receptor 1 gene polymorphisms and adverse pregnancy outcomes: Results of a pilot study in Israel
Sorina Grisaru-Granovsky et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2007)
Protease-activated receptor-1 (hPar1), a survival factor eliciting tumor progression
Zaidoun Salah et al.
MOLECULAR CANCER RESEARCH (2007)
Prevalence of Factor V 1691 G-A (Leiden) and prothrombin G20210A polymorphisms and the risk of venous thrombosis among cancer patients
Aydan Eroglu et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2007)
The pattern of Protease Activated Receptor 1 (PAR1) expression in endometrial carcinoma
Sorina Granovsky-Grisam et al.
GYNECOLOGIC ONCOLOGY (2006)
Thrombin induces tumor growth, metastasis, and angiogenesis: Evidence for a thrombin-regulated dormant tumor phenotype
Mary Lynn Nierodzik et al.
CANCER CELL (2006)
Prevalence of factor V Leiden and prothrombin G20210A in patients with gastric cancer
Sandra Battistelli et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Thrombin generation and the pathogenesis of cancer
Wolfram Ruf et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2006)
The pathogenesis of venous thromboembolism in cancer: emerging links with tumour biology
Paul C. Winter
HEMATOLOGICAL ONCOLOGY (2006)
Proteinase-activated receptors 1 and 4 counter-regulate endostatin and VEGF release from human platelets
L Ma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Increased incidence of neoplasia with persistent activation of the of the digestive tract in men coagulant pathway
GJ Miller et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Protective effect of a thrombin receptor (protease-activated receptor 1) gene polymorphism toward venous thromboembolism
E Arnaud et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Share Paper
